Axsome Therapeutics, Inc. (AXSM) stock
AXSMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$134.00−1.95 (-1.43%)
Close on Nov 18, 2026Market cap $7.02BP/E –Yield –
Axsome Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Axsome Therapeutics's market cap was $7.81B on Nov 11, 2026, against $7.62B a year earlier. Over the last 5 years it ranged from $972.09M to $12.59B, with a median of $4.10B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $7.81B | -15.1% |
| 2025 | Dec 31, 2025 | $9.19B | +124.2% |
| 2024 | Dec 31, 2024 | $4.10B | +8.8% |
| 2023 | Dec 29, 2023 | $3.77B | +12.4% |
| 2022 | Dec 30, 2022 | $3.35B | +135.2% |
| 2021 | Dec 31, 2021 | $1.42B | -53.2% |
| 2020 | Dec 31, 2020 | $3.04B | -14.7% |
| 2019 | Dec 31, 2019 | $3.57B | +4678.8% |
| 2018 | Dec 31, 2018 | $74.61M | -43.7% |
| 2017 | Dec 29, 2017 | $132.53M | +2.5% |
| 2016 | Dec 30, 2016 | $129.29M | +53.3% |
| 2015 | Dec 31, 2015 | $84.35M | – |
See a number that looks wrong?